Renee Ryan

CEO

PinPrint

Renee Ryan is recognized as an industry insider and leading investor, deal-maker, and passionate innovator.

She has over 25 years of building category-creating healthcare companies. Renee currently serves as Founder & CEO of PinPrint, a Stanford spin-out focused on optimizing the patient experience for drug and vaccine delivery. She served as CEO and Board member of Cala Health, a pioneer in the field of wearable neuromodulaton therapy having launched two generations of product and consistently doubled revenue each year of her leadership. Previously, she led the medical technology investments for Johnson & Johnson Innovation (JJDC) on the West Coast and Asia Pacific for 8 years. While at J&J, she made over 15 new investments, including the Series A for Cala Health. Other investments include Auris Health, Carbon 3D, Verb Surgical, PowerVision and Tusker Medical, several of which led to significant acquisitions. Previously, she was a healthcare investment banker at Goldman Sachs and Jefferies. She currently sits on the Boards of RefleXion Medical and Neuropace (NPCE) and OncoRes Medical.

Dr. Nicholas Pachuda

General Partner

Neovate Capital

Dr. Nicholas Pachuda is a General Partner at Neovate Capital, an early-stage life science venture fund. He also serves as the Chief Operating Officer at Peptilogics and sits on several startup boards through his consulting company, Precision Life Science Partners. Previously, Nick was the global leader for External Innovation at J&J Medtech and was part of five successful exits.